Back to search
FDAFDA · Food and drugs·Recall number D-0254-2026

Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0523-01.

Published January 14, 2026 · Recall initiated: December 16, 2025

Summary

FDA records drug Class II recall D-0254-2026, published January 14, 2026 and initiated December 16, 2025. Recalling firm: SpecGx, LLC; Status: Ongoing; Reported quantity: 287,988 Bottles.; Lot: Lot: 0523J23904, expires: 05/2027; 0523J24426, 0523J24427, expires: 06/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.

What to do

Voluntary: Firm initiated · E-Mail

Get an email if OXYCODONE AND ACETAMINOPHEN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
OXYCODONE AND ACETAMINOPHEN
Manufacturer
SpecGx, LLC
Distributor
Nationwide
UPC
0304060522053
Lot
Lot: 0523J23904, expires: 05/2027; 0523J24426, 0523J24427, expires: 06/2027.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0523-01. recalled?

Yes. FDA published recall D-0254-2026 on January 14, 2026. Reported hazard: Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: OXYCODONE AND ACETAMINOPHEN. UPC: 0304060522053.